IMV Inc, a clinical-stage immuno-oncology company, together with its subsidiaries, develops products based on its platform and products with a primary focus on T cell activating therapies for cancer. The company's DPX drug development platform provides a patented delivery formulation that enables controlled and prolonged exposure of antigens to the immune system.
Read More…
Industry, Sector and Symbol
Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone+1-902-4921819
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesC$51,000.00
Profitability
Miscellaneous
Employees51
Next Earnings Date11/1/2019 (Estimated)
OptionableNot Optionable
IMV (TSE:IMV) Frequently Asked Questions
What is IMV's stock symbol?
IMV trades on the Toronto Stock Exchange (TSX) under the ticker symbol "IMV."
How were IMV's earnings last quarter?
Imv Inc (TSE:IMV) announced its earnings results on Thursday, August, 8th. The company reported ($0.10) EPS for the quarter, topping the Thomson Reuters' consensus estimate of ($0.13) by $0.03. The business had revenue of $0.19 million for the quarter, compared to the consensus estimate of $0.10 million. View IMV's Earnings History.
When is IMV's next earnings date?
What price target have analysts set for IMV?
4 brokers have issued 1 year price targets for IMV's stock. Their predictions range from C$10.50 to C$10.50. On average, they expect IMV's share price to reach C$10.50 in the next year. This suggests a possible upside of 160.5% from the stock's current price. View Analyst Price Targets for IMV.
What is the consensus analysts' recommendation for IMV?
4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for IMV in the last year. There are currently 1 hold rating and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for IMV.
Has IMV been receiving favorable news coverage?
Press coverage about IMV stock has trended somewhat positive on Sunday, according to InfoTrie. InfoTrie ranks the sentiment of press coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. IMV earned a daily sentiment score of 0.9 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 1.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the near term. View News Stories for IMV.
Who are some of IMV's key competitors?
Some companies that are related to IMV include Resverlogix (RVX), Kodiak Sciences (KOD), Neptune Wellness Solutions (NEPT), Theratechnologies (TH), Starpharma (SPL), Biotest (BIO), BELLUS Health (BLU), Oxford BioMedica (OXB), ProMetic Life Sciences (PLI), Paradigm Biopharmaceuticals (PAR), Rafael (RFL), CEL-SCI (CVM), Pfenex (PFNX), 22nd Century Group (XXII) and Emerald Health Therapeutics (EMH).
What other stocks do shareholders of IMV own?
Based on aggregate information from My MarketBeat watchlists, some companies that other IMV investors own include International Road Dynamics (IRD), Cronos Group (MJN), Village Farms International (VFF), Aurora Cannabis (ACB), Bombardier, Inc. Class B (BBD.B), ReNeuron Group (RENE), Aphria (APHA), Medical Facilities (DR), MedReleaf (LEAF) and Trevali Mining (TV).
Who are IMV's key executives?
IMV's management team includes the folowing people:
- Mr. Frederic Ors, Pres, CEO & Director (Age 45)
- Mr. Pierre Labbé C.A., C.P.A., CPA, CA, ICD, Chief Financial Officer (Age 54)
- Dr. Gabriela Nicola Rosu M.D., Chief Medical Officer
- Mr. Joseph Sullivan, Sr. VP of Bus. Devel.
- Mr. Marc Jasmin CPA, CMA, Sr. Director of Investor Relations & Communications
How do I buy shares of IMV?
Shares of IMV and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
What is IMV's stock price today?
One share of IMV stock can currently be purchased for approximately C$4.03.
How big of a company is IMV?
What is IMV's official website?
How can I contact IMV?
IMV's mailing address is 1344 Summer Street, Suite 412, HALIFAX, NS B3H 0A8, Canada. The company can be reached via phone at +1-902-4921819.
MarketBeat Community Rating for IMV (TSE IMV)
MarketBeat's community ratings are surveys of what our community members think about IMV and other stocks. Vote "Outperform" if you believe IMV will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IMV will underperform the S&P 500 over the long term. You may vote once every thirty days.
